Comparative Effectiveness of Empagliflozin and Dapagliflozin in Chinese Patients with Type 2 Diabetes Mellitus
Authors
- Xian Xiu (ORCID: https://orcid.org/0009-0000-8705-2492)
- Jingtao Liu (ORCID: https://orcid.org/0000-0001-9378-8623)
- Zan-Chao Liu (ORCID: https://orcid.org/0000-0003-3584-0168)
- Zhe Zhao (ORCID: https://orcid.org/0000-0002-1124-791X)
- Lili Zhang (ORCID: https://orcid.org/0000-0002-4771-4970)
- Panpan Zheng (ORCID: https://orcid.org/0009-0008-4808-0237)
- Yanan Zhao (ORCID: https://orcid.org/0000-0002-7298-6695)
- Jinghua Sun (ORCID: https://orcid.org/0009-0009-5600-8849)
- Meng Du
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Hospital Pharmacy
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1177/00185787251392803
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29